<DOC>
	<DOCNO>NCT00975455</DOCNO>
	<brief_summary>The purpose study evaluate subject gross microscopic hematuria undergo schedule cystoscopy determine absence presence bladder cancer .</brief_summary>
	<brief_title>Hematuria Evaluation Trial Subjects With Microscopic Gross Hematuria Determine Absence Presence Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Hematuria</mesh_term>
	<criteria>For subject family history bladder cancer le 20 pack year history cigarette smoking , subject must 50 old . Subject 's age lower 45 old family history bladder cancer and/or 20 great pack history cigarette smoking . Subject must intact bladder Subject must schedule cystoscopy screen transitional call bladder cancer due find hematuria . Subject must able provide minimum 25 mL urine study purpose . Urine sample must available prior cystoscopy , bladder biopsy , TUR . Subjects must willing sign Institutional Review Board approve write informed consent prior study related procedure perform . Subject history current diagnosis basal squamous cell cancer . Subject know diagnosis autoimmune disease . Subject know diagnosis HIV , HCV HBV Subject disclose voluntarily history current infection TB systemic disease . Subject currently pregnant lactate . Subject surgery within 30 day prior enrollment Subject know allergy benzalkonium chloride . Subject participate investigational drug device trial within 30 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>